High materiality7/10
Revolution Medicines price target raised to $241 from $240 at Truist
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
RVMD target raised to $241 from $240 by Truist Financial; current price $177.96; price +2.78 since signal.
- Target raised to $241; price $177.96; +2.78 since signal.
Key facts
- 01
Target: $241
- 02
Posted price: $177.96
- 03
Analyst firm: Truist Financial
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.